Office of the Executive VP for Research and Innovation

Dr. Lance R. McMahon
Executive Vice President for Research and Innovation
Welcome to the Office of Research and Innovation at The Texas Tech University Health
Sciences Center. Established in 1969, Ìð¹ÏÊÓƵ is comprehensive health sciences center
and multi-campus institution including locations in Lubbock, Amarillo, Abilene, Midland-Odessa,
and Dallas. We are comprised of six schools: Medicine, Pharmacy, Nursing, Health Professions,
Public Health, and Biomedical Sciences. The Office of Research and Innovation partners
with the Offices of Academic Affairs and Clinical Affairs to achieve the major objective
of providing quality academic, research, patient care, and community service programs
to meet the health care needs of West Texas, an area that includes 108 counties and
that represents 50% of the land mass and 9.4% of the total population of the State
of Texas.
Our Mission is to enrich the lives of others by educating students to become collaborative health
care professionals, providing excellent patient care, and advancing knowledge through
innovative research.
Our Vision is to transform health care through innovation and collaboration.
The Office of Research and Innovation staff are dedicated to supporting the research
and development needs of our Ìð¹ÏÊÓƵ community, with the ultimate goal of translating
groundbreaking scientific discoveries into improved health care through widespread
dissemination to the scientific community and creation of new inventions and approaches
to achieve optimal patient outcomes.
Lance R. McMahon, Ph.D., is the Executive Vice President for Research and Innovation at Texas Tech University Health Sciences Center. He is currently Professor of Pharmaceutical Sciences in the Jerry H. Hodge School of Pharmacy and Professor of Medical Education in the School of Medicine. He is chair of the Ìð¹ÏÊÓƵ Research Council, member of the Texas Tech Research Park Board, and member of the Steering Committee of the Center for Translational Neuroscience and Therapeutics. Dr. McMahon is committed to Ìð¹ÏÊÓƵ’s vision to transform healthcare through innovation and collaboration, focusing on advancements in cancer, neuroscience, infectious disease, and cardiometabolic disorders.
Dr. McMahon serves on the Department of Defense Chronic Pain Management Programmatic Panel of the Congressionally Directed Medical Research Program, and he has served as regular and ad hoc study section member of the National Institutes of Health Center for Scientific Review. He has secured $23M in NIH funding for his research in behavioral pharmacology and central nervous system (CNS) drug discovery and development and has published 133 peer-reviewed publications focusing on drugs acting upon the CNS. He has held leadership positions within the American Society of Pharmacology and Experimental Therapeutics and the American Association of Pharmaceutical Scientists, and has served as editor for peer-reviewed journals. Dr. McMahon received his PhD degree from the Department of Psychology at Texas A&M University.
Dr. McMahon builds strategic research partnerships by fostering a collegial spirit, shared vision, and strategic investment of university funds. Ìð¹ÏÊÓƵ is a Hispanic-serving, Carnegie-classified research university, and is proud of its world-class faculty and doctoral trainees who have worked together to secure Ìð¹ÏÊÓƵ’s position as a global leader in academic health-related research.